Skip to main content
Advertisement
Advertisement
BTTC
BTTC logo
Black Titan Corporation Ordinary Shares
0.32
USD
Sponsored
+0.01
+4.42%
Nov 13, 15:53 UTC -5
Closed
exchange

After-Market

0.30

-0.01
-4.24%

Black Titan Corporation Ordinary Shares (BTTC) Earnings

BTTC Earnings Reports

Positive Surprise Ratio

No Data Available for BTTC

0%

Next Report

Date of Next Report
--
Estimate for Q-- -- (Revenue/ EPS)
--
/
--
Implied change from Q2 26 (Revenue/ EPS)
--
/
--
Implied change from Q-- -- (Revenue/ EPS)
--
/
--

Black Titan Corporation Ordinary Shares earnings per share and revenue

On Aug 12, 2026, BTTC reported earnings of -- USD per share (EPS) for Q2 26, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference.
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Pelthos Therapeutics Inc.
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$2.20
Actual
-$3.09
Surprise
-39.99%
logo
Biofrontera Inc. Common Stock
Report Date
Nov 13, 2026 For Q3 26
Estimate
-$0.11
Actual
-$0.42
Surprise
-274.33%
logo
Actuate Therapeutics, Inc. Common stock
Report Date
Nov 13, 2026 For Q3 26
Estimate
-$0.17
Actual
-$0.14
Surprise
+19.26%
logo
Acurx Pharmaceuticals, Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.38
Actual
-$0.49
Surprise
-27.54%
logo
Parabilis Medicines, Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.40
Actual
-$0.36
Surprise
+10.27%
logo
Avalyn Pharma Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.72
Actual
-$0.67
Surprise
+7.92%
logo
Inhibrx Biosciences, Inc. Common Stock
Report Date
Nov 13, 2026 For Q3 26
Estimate
-$2.57
Actual
-$2.46
Surprise
+4.41%
logo
Sagimet Biosciences Inc. Series A Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.26
Actual
-$0.31
Surprise
-17.03%
logo
Monopar Therapeutics Inc. Common Stock
Report Date
Nov 12, 2026 For Q3 26
Estimate
-$0.88
Actual
-$0.72
Surprise
+18.81%
logo
TuHURA Biosciences, Inc. Common Stock
Report Date
Nov 13, 2026 For Q3 26
Estimate
-$0.14
Actual
-$0.10
Surprise
+28.72%
FAQ
For Q2 2026, Black Titan Corporation Ordinary Shares reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
The stock price moved -- --, changed from -- before the earnings release to -- the day after.
The next earning report is scheduled for --.
Based on -- analysts, Black Titan Corporation Ordinary Shares is expected to report EPS of -- and revenue of -- for Q-- --.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement